ZA971607B - Methods of treatment of allergic diseases - Google Patents

Methods of treatment of allergic diseases

Info

Publication number
ZA971607B
ZA971607B ZA971607A ZA971607A ZA971607B ZA 971607 B ZA971607 B ZA 971607B ZA 971607 A ZA971607 A ZA 971607A ZA 971607 A ZA971607 A ZA 971607A ZA 971607 B ZA971607 B ZA 971607B
Authority
ZA
South Africa
Prior art keywords
treatment
methods
allergic diseases
allergic
diseases
Prior art date
Application number
ZA971607A
Inventor
Donald W Masglashan Jr
Daniel C Adelman
James D Reimann
Original Assignee
Univ Johns Hopkins
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Genentech Inc filed Critical Univ Johns Hopkins
Publication of ZA971607B publication Critical patent/ZA971607B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
ZA971607A 1996-03-12 1997-02-25 Methods of treatment of allergic diseases ZA971607B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61422096A 1996-03-12 1996-03-12

Publications (1)

Publication Number Publication Date
ZA971607B true ZA971607B (en) 1998-08-25

Family

ID=24460327

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA971607A ZA971607B (en) 1996-03-12 1997-02-25 Methods of treatment of allergic diseases

Country Status (8)

Country Link
EP (1) EP0904108A1 (en)
JP (1) JP2001505181A (en)
AR (1) AR006202A1 (en)
AU (1) AU726143B2 (en)
CA (1) CA2246427A1 (en)
IL (1) IL126113A0 (en)
WO (1) WO1997033616A1 (en)
ZA (1) ZA971607B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US7393529B2 (en) 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
US20020018778A1 (en) * 1999-12-06 2002-02-14 Caplan Michael J. Passive desensitization
GB0016441D0 (en) 2000-07-04 2000-08-23 Pharmagene Lab Limited Therapeutic method
US6787524B2 (en) 2000-09-22 2004-09-07 Tanox, Inc. CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies
WO2002089615A2 (en) * 2001-05-03 2002-11-14 Novartis Ag Anti-ige antibody to treat ocular allergies
GB201610198D0 (en) * 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies
CN114028569B (en) * 2021-12-20 2023-04-28 中国医学科学院基础医学研究所 Use of immunoglobulin IgE for diagnosis and/or treatment of hypertension
CN114504644B (en) * 2021-12-24 2024-02-13 北京大学第一医院 Use of anti-IgE antibodies for the treatment of adenoid hypertrophy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US4940715A (en) * 1988-05-17 1990-07-10 Kissei Pharmaceutical Co., Ltd. 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
JP3156237B2 (en) * 1991-12-24 2001-04-16 雪印乳業株式会社 Anti-human IgE monoclonal antibody

Also Published As

Publication number Publication date
EP0904108A1 (en) 1999-03-31
AR006202A1 (en) 1999-08-11
AU726143B2 (en) 2000-11-02
JP2001505181A (en) 2001-04-17
CA2246427A1 (en) 1997-09-18
IL126113A0 (en) 1999-05-09
WO1997033616A1 (en) 1997-09-18
AU1987597A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
AU4582797A (en) Methods for treatment of retinal diseases
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
ZA966240B (en) Methods for treatment of allergic asthma.
ZA977263B (en) Treatment of upper airway allergic responses.
GB9617780D0 (en) Method of treatment
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
PL336760A1 (en) Treatment of skin diseases
ZA971607B (en) Methods of treatment of allergic diseases
EP1039883A4 (en) Methods for the treatment of apolipoprotein e related diseases
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
IL131347A0 (en) Treatment of skin disorders
EP1009433A4 (en) Therapeutic composition and method of treatment
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
IL119282A (en) Treatment of fowl
GB9415902D0 (en) Method of treatment
AU3632899A (en) Method for the therapeutic and prophylactic treatment of dental diseases
GB2324962B (en) Treatment of allergic conditions
GB9709451D0 (en) Treatment of allergic conditions
GB9407335D0 (en) Method of treatment
AU3163795A (en) Treatment of autoimmune diseases
ZA968902B (en) Methods and compositions for treatment of diseases
GB9710054D0 (en) Treatment of diseases
GB9602404D0 (en) Methods of treatment